Emory University as of June 30, 2018
Portfolio Holdings for Emory University
Emory University holds 46 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Berkshire Hathaway (BRK.A) | 21.9 | $33M | 117.00 | 282042.74 | |
| Jd (JD) | 10.3 | $16M | 398k | 38.95 | |
| Genomic Health | 2.4 | $3.6M | 71k | 50.40 | |
| Biohaven Pharmaceutical Holding | 2.4 | $3.6M | 90k | 39.52 | |
| Heron Therapeutics (HRTX) | 2.2 | $3.3M | 85k | 38.85 | |
| Seattle Genetics | 2.1 | $3.1M | 47k | 66.40 | |
| Zogenix | 2.0 | $3.1M | 70k | 44.20 | |
| Abiomed | 1.9 | $2.9M | 7.1k | 409.06 | |
| Fox News | 1.9 | $2.9M | 58k | 49.27 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $2.8M | 30k | 94.20 | |
| Amicus Therapeutics (FOLD) | 1.9 | $2.8M | 182k | 15.62 | |
| Neurocrine Biosciences (NBIX) | 1.9 | $2.8M | 29k | 98.23 | |
| Endocyte | 1.9 | $2.8M | 205k | 13.80 | |
| Myovant Sciences | 1.9 | $2.8M | 123k | 22.87 | |
| Alexion Pharmaceuticals | 1.8 | $2.7M | 22k | 124.13 | |
| Ascendis Pharma A S (ASND) | 1.8 | $2.7M | 41k | 66.52 | |
| Incyte Corporation (INCY) | 1.8 | $2.7M | 40k | 67.01 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $2.6M | 26k | 98.49 | |
| Wave Life Sciences (WVE) | 1.7 | $2.6M | 68k | 38.25 | |
| Tg Therapeutics (TGTX) | 1.7 | $2.6M | 196k | 13.15 | |
| Inflarx Nv (IFRX) | 1.7 | $2.5M | 78k | 32.25 | |
| KKR & Co | 1.6 | $2.5M | 100k | 24.85 | |
| Global Blood Therapeutics In | 1.6 | $2.5M | 54k | 45.20 | |
| Alliance Data Systems Corporation (BFH) | 1.6 | $2.4M | 10k | 233.17 | |
| La Jolla Pharmaceuticl Com Par | 1.6 | $2.4M | 83k | 29.17 | |
| Sage Therapeutics (SAGE) | 1.6 | $2.4M | 16k | 156.50 | |
| Armstrong World Industries (AWI) | 1.6 | $2.3M | 37k | 63.21 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $2.2M | 176k | 12.80 | |
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $2.2M | 144k | 15.27 | |
| Cbre Group Inc Cl A (CBRE) | 1.5 | $2.2M | 46k | 47.74 | |
| Dicerna Pharmaceuticals | 1.5 | $2.2M | 180k | 12.25 | |
| Corium Intl | 1.5 | $2.2M | 275k | 8.01 | |
| Beigene (BGNE) | 1.5 | $2.2M | 14k | 153.76 | |
| SLM Corporation (SLM) | 1.4 | $2.1M | 188k | 11.45 | |
| Seagate Technology Com Stk | 1.4 | $2.1M | 38k | 56.47 | |
| Kala Pharmaceuticals | 1.4 | $2.1M | 154k | 13.73 | |
| Trinity Industries (TRN) | 1.4 | $2.1M | 61k | 34.26 | |
| Dbv Technologies S A (DBVT) | 1.4 | $2.1M | 109k | 19.29 | |
| Blueprint Medicines (BPMC) | 1.4 | $2.1M | 33k | 63.47 | |
| Citigroup (C) | 1.3 | $2.0M | 30k | 66.92 | |
| Morgan Stanley (MS) | 1.2 | $1.9M | 40k | 47.40 | |
| Summit Midstream Partners | 0.9 | $1.3M | 88k | 15.40 | |
| Aquinox Pharmaceuticals | 0.4 | $554k | 209k | 2.65 | |
| Cocrystal Pharma Inc Com Par | 0.4 | $560k | 153k | 3.66 | |
| Amazon (AMZN) | 0.2 | $269k | 158.00 | 1702.53 | |
| Spdr S&p 500 Etf (SPY) | 0.2 | $237k | 872.00 | 271.79 |
